Analysts: OncoGenex Pharmaceuticals Inc (OGXI.OQ)

OGXI.OQ on NASDAQ Stock Exchange Capital Market

10.32USD
17 Apr 2014
Price Change (% chg)

$0.07 (+0.68%)
Prev Close
$10.25
Open
$10.29
Day's High
$10.73
Day's Low
$10.13
Volume
69,959
Avg. Vol
74,261
52-wk High
$14.25
52-wk Low
$6.57

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.47 December 19 Apr 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 4 4
(2) OUTPERFORM 2 2 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.25 1.25 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-14 5 8.55 10.00 7.00 --
Quarter Ending Sep-14 5 8.32 10.00 6.00 --
Year Ending Dec-14 8 38.14 66.75 17.50 44.10
Year Ending Dec-15 5 49.32 77.50 23.91 73.39
Earnings (per share)
Quarter Ending Jun-14 5 -0.47 -0.28 -0.60 --
Quarter Ending Sep-14 5 -0.43 -0.23 -0.54 --
Year Ending Dec-14 6 -1.14 0.51 -2.17 -1.43
Year Ending Dec-15 6 0.30 1.74 -1.65 0.95

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-13 10.17 8.60 1.57 15.40
Quarter Ending Sep-13 6.39 9.86 3.47 54.36
Quarter Ending Jun-13 5.73 6.34 0.61 10.57
Quarter Ending Mar-13 5.94 5.08 0.87 14.58
Quarter Ending Dec-12 7.13 9.78 2.65 37.19
Earnings (per share)
Quarter Ending Dec-13 -0.66 -0.45 0.21 -32.21
Quarter Ending Sep-13 -0.69 -0.68 0.01 -1.03
Quarter Ending Jun-13 -0.62 -0.57 0.05 -7.42
Quarter Ending Mar-13 -0.70 -0.46 0.24 -34.75
Quarter Ending Dec-12 -0.50 -0.28 0.22 -44.55

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-14 8.55 8.55 8.55 10.20 --
Quarter Ending Sep-14 8.32 8.32 8.32 9.85 --
Year Ending Dec-14 38.14 38.14 38.14 41.54 44.10
Year Ending Dec-15 49.32 49.32 49.32 48.87 73.39
Earnings (per share)
Quarter Ending Jun-14 -0.47 -0.49 -0.49 -0.49 --
Quarter Ending Sep-14 -0.43 -0.47 -0.47 -0.28 --
Quarter Ending Dec-14 -1.14 -1.34 -1.34 -1.42 -1.43
Quarter Ending Dec-15 0.30 0.30 0.30 -0.53 0.95

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-14 0 0 0 0
Quarter Ending Sep-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Jun-14 0 0 0 0
Quarter Ending Sep-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 1 0 1

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks